Moreover, like any other in vitro experiment, the data presented here unlikely reflects the diverse clinical situations influencing the net effect of IFN-α (viral hepatitis vs. tumor disease without hepatic impairment). The gene discussed is IFNA2; the disease is viral hepatitis.